Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Polycystic Ovary Syndrome × Pioglitazone × Clear all

Phase

Status

Completed 5 Terminated 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Polycystic Ovary Syndrome 1 Hyperinsulinism 1

Interventions

Metformin 9 Letrozole 4 semaglutide 3 Spironolactone 3 Inositol 3 Exercise 3 Clomiphene 3 Caloric Restriction 3 Progesterone 2 xin-kang 1 mirabegron 1 mazdutide 1 maltodextrin 1 drospirenone 1 dapagliflozin 1 artenimol 1 Water 1 Vitamin D 1 Transcranial Direct Current Stimulation 1 Thyroxine 1 Thioctic Acid 1 Tablets 1 Sitagliptin Phosphate 1 Positron-Emission Tomography 1 Pioglitazone 1 Physical Examination 1 Pharmaceutical Preparations 1 Ovidrel 1 Observation 1 Magnesium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05394142 2024-04-22

SPIOMET4HEALTH

Fundació Sant Joan de Déu

Phase 2 Recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡